Monoterapia versus combinaciones en sepsis beta lactam monotherapy versus b-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Br Med J 2004; 328: 668-82

Ejemplares similares

• Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
  por: Paul Skorup, et al.
  Publicado: (2014)
• In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams.
  por: Fiona Fouhy, et al.
  Publicado: (2013)
• Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
  por: Dimard E. Foudraine, et al.
  Publicado: (2021)
• Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site
  por: Zainab Edoo, et al.
  Publicado: (2017)
• Amide nitrogen pyramidalization changes lactam amide spinning
  por: Yuko Otani, et al.
  Publicado: (2019)